Atlas Trials

Adult Solid Tumor

26 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Adult Solid Tumor

RecordFirmDate
Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of HLX26 and HLX10 in Patients With Advanced/Metastatic Solid Tumor (NCT05400265)Shanghai Henlius Biotech2022-07-26
Study of SQZ-eAPC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors (NCT05357898)SQZ Biotechnologies2022-03-24
Study of RP-6306 With Gemcitabine in Advanced Solid Tumors (NCT05147272)Debiopharm International SA2021-12-16
Study of SQZ-AAC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors (NCT04892043)SQZ Biotechnologies2021-08-19
Combining Epigenetic And Immune Therapy to Beat Cancer. (NCT04705818)Institut Bergonié2021-07-23
Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Cancer Therapy (NCT04538625)Napo Pharmaceuticals, Inc.2020-10-07
Human Leukocyte Antigen Typing and Tumor Antigen Expression Profiling (NCT03760952)Immatics US, Inc.2019-02-26
Hydrogen Gas for Cancer Rehabilitation (NCT03818347)Fuda Cancer Hospital, Guangzhou2018-06-02
Cyberknife Radiosurgery for Patients With Brain Metastases Diagnosed With Either SPACE or MPRAGE Sequence (NCT03303365)Juergen Debus2018-02-01
CANscriptTM Clinical Outcomes in a Real-World Setting (ANCERS)-2 (NCT03253575)Mitra RxDx, Inc.2017-07-13
Assessing the Clinical Benefit of Molecular Profiling in Patients With Solid Tumors (NCT03061305)Strata Oncology2016-11-01
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) (NCT02568267)Hoffmann-La Roche2015-11-19
A Phase I Trial of AZD3965 in Patients With Advanced Cancer (NCT01791595)Cancer Research UK2013-04-23
A Comparison of Remifentanil and Dexmedetomidine for Craniotomy Perioperative Hemodynamics and Postoperative Pain (NCT01269918)The Cleveland Clinic2011-07-01
Study of TRC105 Combined With Standard-Dose Bevacizumab for Advanced Solid Tumors for Which Bevacizumab is Indicated (NCT01332721)Tracon Pharmaceuticals Inc.2011-04-01
Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer (NCT01037790)Abramson Cancer Center at Penn Medicine2009-10-01
Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery (NCT00041171)Alliance for Clinical Trials in Oncology

Track Adult Solid Tumor automatically

Every clearance here is in the API, with alerts when new ones post.